The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.
The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.
The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors. 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.
The Journal seeks original manuscripts devoted to fundamental science in cardiovascular disease, laboratory investigation, pharmacogenetics, clinical research, global health and epidemiology. State-of-the-art reviews, position papers and editorials will be summoned by invitation from the editor or an appointed guest editor. The Journal will publish special issues and supplements from national and international symposia and scientific committees in a timely fashion by working closely with organizers and contributing authors. 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Richard Becker
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.054 (2019)
- Impact factor
- 2.123 (2019)
- Five year impact factor
- 29 days
- Submission to first decision
- 65 days
- Submission to acceptance
- 202,674 (2019)
- Downloads
Latest issue
Latest articles
-
-
-
Different endovascular procedures for stroke with isolated M2-segment MCA occlusion: a real-world experience
Authors (first, second and last of 14)
-
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients
Authors (first, second and last of 6)
-
Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study
Authors (first, second and last of 4)
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
About this journal
- Electronic ISSN
- 1573-742X
- Print ISSN
- 0929-5305
- Abstracted and indexed in
-
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Neurosciences Abstracts
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Qinsight
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature